Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks.
Development of novel carriers and optimization of their design parameters has led to significant advances in the field of targeted drug delivery. Since carrier shape has recently been recognized as an important design parameter for drug delivery, we sought to investigate how carrier shape influences their flow in the vasculature and their ability to target the diseased site. Idealized synthetic microvascular networks (SMNs) were used for this purpose since they closely mimic key physical aspects of real vasculature and at the same time offer practical advantages in terms of ease of use and direct observation of particle flow. The attachment propensities of surface functionalized spheres, elliptical/circular disks and rods with dimensions ranging from 1microm to 20microm were compared by flowing them through bifurcating SMNs. Particles of different geometries exhibited remarkably different adhesion propensities. Moreover, introduction of a bifurcation as opposed to the commonly used linear channel resulted in significantly different flow and adhesion behaviors, which may have important implications in correlating these results to in vivo behavior. This study provides valuable information for design of carriers for targeted drug delivery.
Doshi
Nishit
N
Department of Chemical Engineering, University of California, Santa Barbara, CA 93106, USA.
Prabhakarpandian
Balabhaskar
B
Rea-Ramsey
Angela
A
Pant
Kapil
K
Sundaram
Shivshankar
S
Mitragotri
Samir
S
D000818:Animals; D002417:Cattle; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism*; D055806:Microvessels / Q000378:metabolism*; D008954:Models, Biological; D012710:Serum Albumin, Bovine / Q000737:chemistry
D004337:Drug Carriers; D012710:Serum Albumin, Bovine
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20
16606824
Nat Nanotechnol. 2007 Apr;2(4):249-55
18654271
Pharmacol Rev. 2001 Jun;53(2):283-318
11356986
Nature. 1998 Apr 30;392(6679 Suppl):5-10
9579855
Biomed Microdevices. 2008 Aug;10(4):585-95
18327641
Int J Nanomedicine. 2007;2(4):689-96
18203435
Mol Ther. 2008 Aug;16(8):1450-8
18560419
J Biomech. 2008 Jul 19;41(10):2312-8
18571181
Pharm Res. 2009 Jan;26(1):235-43
18712584
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8
18697944
Mol Pharm. 2008 Jul-Aug;5(4):505-15
18672949
J Cell Biol. 1994 Jun;125(6):1417-27
7515891
Biomed Microdevices. 2009 Oct;11(5):1051-7
19452279
Science. 1998 Jan 16;279(5349):377-80
9430587
Biotechnol Bioeng. 2007 Feb 15;96(3):596-607
16917925
Lab Chip. 2009 Jul 7;9(13):1897-902
19532965
Langmuir. 2008 Aug 19;24(16):8821-32
18630976
Adv Drug Deliv Rev. 2000 Mar 30;41(2):147-62
10699311
Biophys J. 2001 Apr;80(4):1733-43
11259287
Adv Mater. 2008 May 5;20(9):1630-1635
21687830
Biotechnol Bioeng. 2007 Feb 1;96(2):203-9
17191251
Curr Protoc Cell Biol. 2003 May;Chapter 9:Unit 9.6
18228437
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
16549762
Ann Biomed Eng. 2005 Feb;33(2):179-90
15771271
JAMA. 1999 Dec 1;282(21):2035-42
10591386
Nat Mater. 2009 Jan;8(1):15-23
19096389
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11901-4
17620615
Ann Biomed Eng. 2009 Jul;37(7):1331-41
19440840
Nat Rev Drug Discov. 2006 Feb;5(2):147-59
16424916